IN-VIVO EVALUATION OF SPRAY FORMULATIONS OF HUMAN INSULIN FOR NASAL DELIVERY

被引:40
|
作者
DONDETI, P [1 ]
ZIA, HS [1 ]
NEEDHAM, TE [1 ]
机构
[1] UNIV RHODE ISL,COLL PHARM,DEPT PHARMACEUT,KINGSTON,RI 02881
关键词
INSULIN; HUMAN; NASAL ADMINISTRATION; SPRAY FORMULATION; BIOADHESIVE POLYMER; MICROCRYSTALLINE CELLULOSE; PLASTOID; AMMONIUM GLYCYRRHIZINATE; GLYCYRRHETINIC ACID; SODIUM TAUROCHOLATE;
D O I
10.1016/0378-5173(95)00045-K
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are many ongoing investigations to improve the nasal bioavailability of peptide and protein formulations. The presence of bioadhesive polymers in nasal formulations may increase the residence time of the drugs in the nasal cavity. A combination of bioadhesive polymers with permeation enhancers would seem to further improve nasal bioavailability. In this study, insulin spray formulations containing two bioadhesive polymers (1.5% w/v microcrystalline cellulose (MCC) and 70% w/w Plastoid L50) alone or in combination with the enhancers such as sodium taurocholate (ST), ammonium glycyrrhizinate (AG) or glycyrrhetinic acid (GA) at 1% w/v level, were evaluated in diabetic rabbits. A total volume of 100 mu l of freshly prepared insulin formulation was sprayed into the nasal cavity of each diabetic rabbit. Glucose levels were monitored using a blood glucose assay and serum insulin levels were analyzed using RIA. 5 U/kg insulin in the MCC suspension alone resulted in an absolute bioavailability of 1.96% while Plastoid L50 alone resulted in 2.25% absolute bioavailability. Insulin in the MCC suspension and ST, AG or GA resulted in 8.36, 7.83 and 2.15% bioavailability, respectively. The same formulations produced a hypoglycemic effect in terms of total glucose reductions of 39.12, 15.96 and 9.36% and the maximal decreases in glucose levels were 58.37, 21.8 and 18.61%, respectively. The Plastoid formulation containing 1% ST provided nasal insulin bioavailability of 5.9% with a total glucose reduction of 17.03% and a maximal glucose decrease of 26.56%. Insulin spray formulations containing 1% ST alone and 1% AG alone resulted in bioavailabilities of 7.25 and 3.57%, respectively. These same sprays provided total glucose reductions of 25.08 and 16.97% with maximal glucose decreases of 44.56 and 19.81%, respectively. The presence of benzalkonium chloride and 2-phenylethanol as preservatives in the MCC suspension resulted in higher insulin absorption than the same formulation without preservatives (6.31% vs 1.96%).
引用
收藏
页码:91 / 105
页数:15
相关论文
共 50 条
  • [1] DEXTRAN MICROSPHERES AS A POTENTIAL NASAL DRUG-DELIVERY SYSTEM FOR INSULIN - IN-VITRO AND IN-VIVO PROPERTIES
    PERESWETOFFMORATH, L
    EDMAN, P
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 124 (01) : 37 - 44
  • [2] OPHTHALMIC AND NASAL DELIVERY OF INSULIN FROM OILY SUSPENSIONS IN RABBITS IN-VITRO AND IN-VIVO
    YAMAMOTO, T
    MAITANI, Y
    MACHIDA, Y
    NAGAI, T
    STP PHARMA SCIENCES, 1994, 4 (02): : 133 - 138
  • [3] In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan
    Krauland, Alexander H.
    Leitner, Verena M.
    Grabovac, Vjera
    Bernkop-Schnuerch, Andreas
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (11) : 2463 - 2472
  • [4] CYCLODEXTRINS AS PROTECTION AGENTS AGAINST ENHANCER DAMAGE IN NASAL DELIVERY SYSTEMS .2. EFFECT ON IN-VIVO ABSORPTION OF INSULIN AND HISTOPATHOLOGY OF NASAL MEMBRANE
    GILL, IJ
    FISHER, AN
    HINCHCLIFFE, M
    WHETSTONE, J
    FARRAJ, N
    DEPONTI, R
    ILLUM, L
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 1 (05) : 237 - 248
  • [5] In vivo systemic evaluation of nasal drug absorption from powder formulations in rats
    Tatsuta, Ryosuke
    Tanaka, Akiko
    Ogawara, Ken-ichi
    Higaki, Kazutaka
    Furubayashi, Tomoyuki
    Sakane, Toshiyasu
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2025, 207
  • [6] Nasal insulin delivery in the chitosan solution:: in vitro and in vivo studies
    Yu, SY
    Zhao, Y
    Wu, FL
    Zhang, X
    Lü, WL
    Zhang, H
    Zhang, Q
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 281 (1-2) : 11 - 23
  • [7] Development and evaluation of nasal formulations of ketorolac
    Quadir, M
    Zia, H
    Needham, TE
    DRUG DELIVERY, 2000, 7 (04) : 223 - 229
  • [8] In vivo evaluation of alginate microspheres of carvedilol for nasal delivery
    Patil, Sanjay B.
    Kaul, Ankur
    Babbar, Anil
    Mathur, Rashi
    Mishra, Anil
    Sawant, Krutika K.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2012, 100B (01) : 249 - 255
  • [9] Towards the nasal delivery of insulin
    Nazar, Hamde
    Tsibouklis, John
    THERAPEUTIC DELIVERY, 2012, 3 (11) : 1241 - 1243
  • [10] Effect of insulin concentration on bioavailability during nasal spray administration
    Valensi, P
    Zirinis, P
    Nicolas, P
    Perret, G
    SandreBanon, D
    Attalii, JR
    PATHOLOGIE BIOLOGIE, 1996, 44 (04): : 235 - 240